Formulation development and characterization of galantamine hydrobromide extended-release capsules (8mg)

Alli Srija; M. Sunitha Reddy; K. Hari Krishna; A. Vijay Reddy

doi:10.30574/ijsra.2023.10.2.1021

ISSN Approved Journal || eISSN: 2582-8185 || CODEN: IJSRO2 || Impact Factor 8.2 || Google Scholar and CrossRef Indexed

Peer Reviewed and Referred Journal || Free Certificate of Publication

Research and review articles are invited for publication in March 2026 (Volume 18, Issue 3) Submit manuscript

Formulation development and characterization of galantamine hydrobromide extended-release capsules (8mg)

Alli Srija ^*, M. Sunitha Reddy, K. Hari Krishna and A. Vijay Reddy

Department of Pharmaceutics, Centre for Pharmaceutical Sciences, UCEST, Jawaharlal Nehru Technological University Hyderabad, Kukatpally, Hyderabad, 500085, Telangana, India

Research Article

International Journal of Science and Research Archive, 2023, 10(02), 806–816.

Article DOI: 10.30574/ijsra.2023.10.2.1021

DOI url: https://doi.org/10.30574/ijsra.2023.10.2.1021

Publication history

Received on 01 November 2023; revised on 10 December 2023; accepted on 12 December 2023

Abstract

The aim of the present work is to develop extended-release capsules of Galantamine HBr (8mg) and compare them with the reference listed drug (Reminyl or Razadyne). The capsules were prepared using Pelletization technique and evaluated for preformulation characteristics, physical, and chemical parameters. The In-vitro dissolution studies were conducted using USP type II (paddle apparatus) in 900 ml of pH 6.5 phosphate buffer. Among all the formulations, F7 was found to be pharmaceutically equivalent to reference listed drug due to its similarity factor (f2= 96) in drug release profile. The F7 formulation was loaded for stability study and no change was observed, which indicates that the optimized F7 formulation was stable.

Keywords

Galantamine HBr; Reminyl or Razadyne; Pelletization technology; USP type II

Download Article PDF

https://ijsra.net/sites/default/files/fulltext_pdf/IJSRA-2023-1021.pdf

Preview Article PDF

How to cite this article

Alli Srija, M. Sunitha Reddy, K. Hari Krishna and A. Vijay Reddy. Formulation development and characterization of galantamine hydrobromide extended-release capsules (8mg). International Journal of Science and Research Archive, 2023, 10(02), 806–816. Article DOI: https://doi.org/10.30574/ijsra.2023.10.2.1021

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.